Home › Funds › PNC Financial Services › NRIX
PNC Financial Services position in NRIX
NURIX THERAPEUTICS INC · Health Care
Latest position (Q2 2026)600 sh
Reported value held$14.56K
Portfolio Weight0.00%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 4 | $59 | New |
| Q2 2024 | 17 | $355 | Add |
| Q3 2024 | 17 | $382 | Hold |
| Q4 2024 | 17 | $320 | Hold |
| Q1 2025 | 54 | $642 | Add |
| Q2 2025 | 130 | $1.48K | Add |
| Q3 2025 | 440 | $4.07K | Add |
| Q4 2025 | 450 | $8.54K | Add |
| Q1 2026 | 450 | $6.97K | Hold |
| Q2 2026 | 600 | $14.56K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NRIX
- BlackRock Inc 8.77M sh · $212.77M · Q2 2026
- Fidelity Management & Research (FMR) 5.49M sh · $133.07M · Q2 2026
- Morgan Stanley 4.76M sh · $115.54M · Q2 2026
- Vanguard Group 5.95M sh · $112.86M · Q4 2025
- Geode Capital Management 2.54M sh · $61.57M · Q2 2026
- ARK Invest 1.79M sh · $43.50M · Q2 2026
- Capital World Investors 1.79M sh · $43.37M · Q2 2026
- Citadel Advisors 1.53M sh · $37.10M · Q2 2026
- UBS Group AG 917.12K sh · $22.25M · Q2 2026
- Northern Trust Corp 876.07K sh · $21.25M · Q2 2026
- Bank of America Corp 842.09K sh · $20.43M · Q2 2026
- Charles Schwab Investment Management 833.30K sh · $20.22M · Q2 2026